LinkedIn Profile

Access New Haven Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:newhavenpharmaceuticals 786122 May 30th, 2019 12:00AM New Haven Pharmaceuticals, Inc. 943 7.00 Open Pharmaceuticals May 30th, 2019 01:56PM May 30th, 2019 01:56PM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Open Pharmaceuticals, Gastrointestinal, Cardiovascular Open 116 Washington Avenue North Haven CT US 06473 Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Dec 16th, 2017 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Dec 16th, 2017 02:21PM Dec 16th, 2017 02:21PM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Dec 17th, 2017 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Dec 17th, 2017 08:12AM Dec 17th, 2017 08:12AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Dec 18th, 2017 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Dec 18th, 2017 10:19AM Dec 18th, 2017 10:19AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Dec 19th, 2017 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Dec 19th, 2017 05:03AM Dec 19th, 2017 05:03AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Dec 21st, 2017 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Dec 21st, 2017 12:42PM Dec 21st, 2017 12:42PM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Dec 22nd, 2017 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Dec 22nd, 2017 05:53AM Dec 22nd, 2017 05:53AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Dec 23rd, 2017 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Dec 23rd, 2017 09:37AM Dec 23rd, 2017 09:37AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Dec 24th, 2017 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Dec 24th, 2017 01:22PM Dec 24th, 2017 01:22PM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology
private:newhavenpharmaceuticals 786122 Dec 25th, 2017 12:00AM New Haven Pharmaceuticals, Inc. 919 11.00 Open Pharmaceuticals Dec 25th, 2017 10:21AM Dec 25th, 2017 10:21AM New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible. Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.